Back to BEAM

Elmind Capital, LP → BEAM

Elmind Capital, LP BEAM Position History

Beam Therapeutics Inc.

Quarters held
4
Latest value
$11.6M
Q3 2026
Peak value
$16.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$13.2M
Q1 2026$11.4M
Q2 2026$16.3M
Q3 2026$11.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$11.6M476.3K——
Q2 2026$16.3M476.3K——
Q1 2026$11.4M476.3K——
Q4 2025$13.2M476.3K——

Other funds holding BEAM

Other Elmind Capital, LP positions

COGT

COGENT BIOSCIENCES INC

$45.3M
COGT

COGENT BIOSCIENCES INC

$45.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$43.3M
COGT

COGENT BIOSCIENCES INC

$41.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$40.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$39M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36M